SCHEMBL20174203

SCHEMBL20174203

c1ccc(-c2nc(-c3ccccc3)nc(-c3ccccc3-c3ccc4c(c3)-c3ccccc3C43c4ccccc4-c4oc5ccccc5c43)n2)cc1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.33
KMT2A Q03164 4/20 0.33
LMNA P02545 2/20 0.33
TSHR P16473 2/20 0.33
POLB P06746 1/20 0.33
HTT P42858 1/20 0.33
ALOX5 P09917 1/20 0.32
MEN1 O00255 3/20 0.32
ALDH1A1 P00352 3/20 0.32
HPGD P15428 3/20 0.32
PLA2G2A P14555 1/20 0.32
PLA2G4A P47712 1/20 0.32
KDM4E B2RXH2 2/20 0.32
ATM Q13315 2/20 0.32
TP53 P04637 1/20 0.32
NFKB1 P19838 1/20 0.32
MAPK1 P28482 1/20 0.32
NFKB2 Q00653 1/20 0.32
RELA Q04206 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20174205 0.94 ALOX5 (0.32) MAPTKMT2ALMNATSHRPOLB
SCHEMBL20174246 0.93 PLA2G2A (0.34) MAPTKMT2ALMNATSHRPOLB
SCHEMBL20174276 0.93 PLA2G2A (0.33) MAPTKMT2ALMNATSHRPOLB
SCHEMBL20174229 0.90 MAPT (0.36) MAPTKMT2ALMNATSHRPOLB
SCHEMBL20174238 0.90 ALDH1A1 (0.36) MAPTKMT2ALMNATSHRALOX5
SCHEMBL20174240 0.88 KMT2A (0.41) MAPTKMT2ALMNATSHRPOLB
SCHEMBL20174239 0.88 KMT2A (0.33) MAPTKMT2ALMNATSHRMEN1
SCHEMBL20174249 0.88 ALDH1A1 (0.33) MAPTKMT2ATSHRMEN1ALDH1A1
SCHEMBL20174200 0.88 MAPT (0.34) MAPTKMT2ALMNATSHRPOLB
SCHEMBL20174291 0.87 KMT2A (0.38) MAPTKMT2ALMNATSHRPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10738034-B2 Spiro compound and organic light-emitting device comprising same LG CHEM, LTD. (KR) 2020-08-11 US disclosed
US-20180141933-A1 SPIRO COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2018-05-24 US disclosed
US-20180141933-A1 SPIRO COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2018-05-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10738034-B2 Spiro compound and organic light-emitting device comprising same CRY1, NR2E3, ERG MAPT 811/4885KMT2A 1480/4885LMNA 3057/4885
US-20180141933-A1 SPIRO COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME CRY1, NR2E3, ERG MAPT 811/4885KMT2A 1480/4885LMNA 3057/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.